193 related articles for article (PubMed ID: 23537062)
1. Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.
Murgai M; Thomas J; Cherepanova O; Delviks-Frankenberry K; Deeble P; Pathak VK; Rekosh D; Owens G
Retrovirology; 2013 Mar; 10():34. PubMed ID: 23537062
[TBL] [Abstract][Full Text] [Related]
2. Phylogenetic and biological analysis of a laboratory-generated gammaretrovirus xenotropic murine leukemia virus-related virus (XMRV).
Ma X; Zhou S; Wei M; Chen Y; Li J; Xiong W; Jiang S; Pan C
Virus Genes; 2012 Oct; 45(2):218-24. PubMed ID: 22735937
[TBL] [Abstract][Full Text] [Related]
3. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.
Sakuma T; De Ravin SS; Tonne JM; Thatava T; Ohmine S; Takeuchi Y; Malech HL; Ikeda Y
Hum Gene Ther; 2010 Dec; 21(12):1665-73. PubMed ID: 20507233
[TBL] [Abstract][Full Text] [Related]
4. Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.
Kakoki K; Kamiyama H; Izumida M; Yashima Y; Hayashi H; Yamamoto N; Matsuyama T; Igawa T; Sakai H; Kubo Y
Biochem Biophys Res Commun; 2014 Apr; 447(1):216-22. PubMed ID: 24721431
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells.
Dey A; Mantri CK; Pandhare-Dash J; Liu B; Pratap S; Dash C
Virol J; 2011 Dec; 8():531. PubMed ID: 22152111
[TBL] [Abstract][Full Text] [Related]
6. Disease-associated XMRV sequences are consistent with laboratory contamination.
Hué S; Gray ER; Gall A; Katzourakis A; Tan CP; Houldcroft CJ; McLaren S; Pillay D; Futreal A; Garson JA; Pybus OG; Kellam P; Towers GJ
Retrovirology; 2010 Dec; 7(1):111. PubMed ID: 21171979
[TBL] [Abstract][Full Text] [Related]
7. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.
Lee D; Das Gupta J; Gaughan C; Steffen I; Tang N; Luk KC; Qiu X; Urisman A; Fischer N; Molinaro R; Broz M; Schochetman G; Klein EA; Ganem D; Derisi JL; Simmons G; Hackett J; Silverman RH; Chiu CY
PLoS One; 2012; 7(9):e44954. PubMed ID: 23028701
[TBL] [Abstract][Full Text] [Related]
8. Investigation of xenotropic murine leukemia virus-related virus (XMRV) in human and other cell lines.
Williams DK; Galvin TA; Ma H; Khan AS
Biologicals; 2011 Nov; 39(6):378-83. PubMed ID: 21996050
[TBL] [Abstract][Full Text] [Related]
9. Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors.
Zhou Y; Steffen I; Montalvo L; Lee TH; Zemel R; Switzer WM; Tang S; Jia H; Heneine W; Winkelman V; Tailor CS; Ikeda Y; Simmons G
Transfusion; 2012 Feb; 52(2):332-42. PubMed ID: 22239212
[TBL] [Abstract][Full Text] [Related]
10. Primate gammaretroviruses require an ancillary factor not required for murine gammaretroviruses to infect BHK cells.
Xu W; Eiden MV
J Virol; 2011 Apr; 85(7):3498-506. PubMed ID: 21270153
[TBL] [Abstract][Full Text] [Related]
11. No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.
Rezaei SD; Hearps AC; Mills J; Pedersen J; Tachedjian G
Virol J; 2013 Jan; 10():20. PubMed ID: 23305518
[TBL] [Abstract][Full Text] [Related]
12. No evidence of cross-species transmission of mouse retroviruses to animal workers exposed to mice.
Brooks J; Lycett-Lambert K; Caminiti K; Merks H; McMillan R; Sandstrom P
Transfusion; 2012 Feb; 52(2):317-25. PubMed ID: 22212105
[TBL] [Abstract][Full Text] [Related]
13. XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?
Stieler K; Schumacher U; Horst AK; Fischer N
PLoS One; 2012; 7(7):e42321. PubMed ID: 22848758
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.
Curriu M; Carrillo J; Massanella M; Garcia E; Cunyat F; Peña R; Wienberg P; Carrato C; Areal J; Bofill M; Clotet B; Blanco J; Cabrera C
PLoS One; 2012; 7(5):e37415. PubMed ID: 22616002
[TBL] [Abstract][Full Text] [Related]
15. No association of xenotropic murine leukemia virus-related viruses with prostate cancer.
Switzer WM; Jia H; Zheng H; Tang S; Heneine W
PLoS One; 2011 May; 6(5):e19065. PubMed ID: 21573232
[TBL] [Abstract][Full Text] [Related]
16. Recombinant origin of the retrovirus XMRV.
Paprotka T; Delviks-Frankenberry KA; Cingöz O; Martinez A; Kung HJ; Tepper CG; Hu WS; Fivash MJ; Coffin JM; Pathak VK
Science; 2011 Jul; 333(6038):97-101. PubMed ID: 21628392
[TBL] [Abstract][Full Text] [Related]
17. Membrane fusion and cell entry of XMRV are pH-independent and modulated by the envelope glycoprotein's cytoplasmic tail.
Côté M; Zheng YM; Liu SL
PLoS One; 2012; 7(3):e33734. PubMed ID: 22479434
[TBL] [Abstract][Full Text] [Related]
18. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.
Das Gupta J; Luk KC; Tang N; Gaughan C; Klein EA; Kandel ES; Hackett J; Silverman RH
PLoS One; 2012; 7(5):e36072. PubMed ID: 22615748
[TBL] [Abstract][Full Text] [Related]
19. Lack of the detection of XMRV or polytropic MLV-related sequences in blood cells from HIV-1-infected patients in Spain.
Luczkowiak J; Martínez-Prats L; Sierra O; Fiorante S; Rubio R; Pulido F; Otero JR; Delgado R
J Acquir Immune Defic Syndr; 2012 Feb; 59(2):101-4. PubMed ID: 21963942
[TBL] [Abstract][Full Text] [Related]
20. Characterization, mapping, and distribution of the two XMRV parental proviruses.
Cingöz O; Paprotka T; Delviks-Frankenberry KA; Wildt S; Hu WS; Pathak VK; Coffin JM
J Virol; 2012 Jan; 86(1):328-38. PubMed ID: 22031947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
